A Study of XW001 in Healthy Adult Subjects

NCT05642403 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

81

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Syncytial Virus Infections

Interventions

DRUG: XW001
DRUG: Placebo

Sponsor

Hangzhou Sciwind Biosciences Co., Ltd.